# Cybin Inc. (CYBN)

Source: https://www.quantisnow.com/company/CYBN
Generated: 2026-11-19T08:23:13.494Z

- Ticker: CYBN
- Exchange: AMEX
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- Website: cybin.com

## About

Cybin Inc., a biotechnology company, focuses on developing psychedelic therapeutics to treat various psychiatric and neurological conditions. The company operates through two segments, Serenity Life and Cybin U.S., and Natures Journey. The Serenity Life and Cybin U.S. segment engages in the research and development of psychedelic pharmaceutical products. The Natures Journey segment focuses on non-psychedelic medicinal mushroom nutraceutical products. It develops CYB001, a drug candidate that is in phase IIa/b for major depressive disorder; CYB003, a deuterated tryptamine preclinical program to treat alcohol use disorder; CYB004, a deuterated tryptamine preclinical program for therapy resistant psychiatric disorder; and CYB005, a phenethylamine preclinical program for psychiatry and neurology. The company offers its products through various form factors, such as capsules, powders, and effervescent tablets. Cybin Inc. is headquartered in Toronto, Canada.

## Latest CYBN news and filings

- 2026-01-05 21:51 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6335536)
- 2026-01-05 12:30 UTC [HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq](https://www.quantisnow.com/insight/helus-pharma-propels-therapeutic-innovation-in-mental-health-and-commences-6333119)
- 2026-01-02 16:06 UTC [SEC Form CERT filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-cert-filed-by-cybin-inc-6331656)
- 2026-01-02 11:14 UTC [SEC Form 8-A12B filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-8-a12b-filed-by-cybin-inc-6331323)
- 2026-01-02 11:11 UTC [SEC Form 25 filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-25-filed-by-cybin-inc-6331321)
- 2025-12-31 20:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6330767)
- 2025-12-30 21:21 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6330001)
- 2025-12-30 21:20 UTC [SEC Form SUPPL filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-suppl-filed-by-cybin-inc-6329992)
- 2025-12-30 20:33 UTC [Cybin Initiates At-The-Market Equity Program of up to US$100 Million](https://www.quantisnow.com/insight/cybin-initiates-at-the-market-equity-program-of-up-to-us100-million-6329750)
- 2025-12-22 22:06 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6325747)
- 2025-12-19 21:36 UTC [SEC Form F-X] [SEC Form F-X filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-f-x-filed-by-cybin-inc-6324007)
- 2025-12-19 21:27 UTC [SEC Form F-10 filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-f-10-filed-by-cybin-inc-6323914)
- 2025-12-18 22:07 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6322557)
- 2025-12-18 12:30 UTC [Leadership Update] [Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq](https://www.quantisnow.com/insight/cybin-to-transfer-us-stock-exchange-listing-to-nasdaq-6321225)
- 2025-11-26 16:46 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6294773)
- 2025-11-14 21:16 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Cybin Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-cybin-inc-6280666)
- 2025-11-13 12:24 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6276088)
- 2025-11-13 12:20 UTC [Public Offering] [Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights](https://www.quantisnow.com/insight/cybin-reports-second-quarter-fiscal-year-2026-financial-results-and-6276084)
- 2025-11-12 16:10 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6273659)
- 2025-11-12 12:30 UTC [Conference Announcement] [Cybin to Participate in the Jefferies Global Healthcare Conference in London](https://www.quantisnow.com/insight/cybin-to-participate-in-the-jefferies-global-healthcare-conference-in-6272802)
- 2025-11-07 21:38 UTC [SEC Form SCHEDULE 13G filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-cybin-inc-6268604)
- 2025-11-06 21:40 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6266327)
- 2025-11-06 12:30 UTC [Earnings Date] [Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025](https://www.quantisnow.com/insight/cybin-to-announce-second-quarter-financial-results-and-provide-business-6264089)
- 2025-11-05 20:19 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6261969)
- 2025-11-05 12:30 UTC [Conference Announcement] [Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference](https://www.quantisnow.com/insight/cybin-to-participate-in-the-guggenheim-2nd-annual-healthcare-innovation-6260991)
- 2025-11-03 19:43 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6256251)
- 2025-11-03 12:30 UTC [Conference Announcement] [Cybin to Participate at the 2025 Milken Institute Future of Health Summit](https://www.quantisnow.com/insight/cybin-to-participate-at-the-2025-milken-institute-future-of-6255436)
- 2025-10-31 21:13 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6254941)
- 2025-10-31 20:19 UTC [Public Offering] [Cybin Announces Closing of $175 Million Registered Direct Offering](https://www.quantisnow.com/insight/cybin-announces-closing-of-175-million-registered-direct-offering-6254647)
- 2025-10-29 01:59 UTC [SEC Form SUPPL filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-suppl-filed-by-cybin-inc-6248756)
- 2025-10-29 10:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6248751)
- 2025-10-28 14:27 UTC [SEC Form FWP] [SEC Form FWP filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-cybin-inc-6247422)
- 2025-10-28 14:25 UTC [SEC Form FWP] [SEC Form FWP filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-cybin-inc-6247420)
- 2025-10-28 12:52 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6247261)
- 2025-10-28 12:10 UTC [SEC Form FWP] [SEC Form FWP filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-fwp-filed-by-cybin-inc-6247116)
- 2025-10-28 12:00 UTC [Public Offering] [Cybin Announces $175 Million Registered Direct Offering](https://www.quantisnow.com/insight/cybin-announces-175-million-registered-direct-offering-6247039)
- 2025-10-15 18:19 UTC [SEC Form D] [SEC Form D filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-cybin-inc-6233837)
- 2025-09-23 21:24 UTC [SEC Form 6-K] [SEC Form 6-K filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-cybin-inc-6209694)
- 2025-09-23 21:00 UTC [Cybin Highlights Neuropsychiatry Platform and Upcoming Clinical Milestones](https://www.quantisnow.com/insight/cybin-highlights-neuropsychiatry-platform-and-upcoming-clinical-milestones-6209603)
- 2025-09-22 23:42 UTC [SEC Form D] [SEC Form D filed by Cybin Inc.](https://www.quantisnow.com/insight/sec-form-d-filed-by-cybin-inc-6208656)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CYBN
- Earnings history: https://www.quantisnow.com/earnings/CYBN
- Dividend history: https://www.quantisnow.com/dividends/CYBN
- Insider transactions: https://www.quantisnow.com/insiders/CYBN
- Options chain: https://www.quantisnow.com/options/CYBN
- SEC 8-K filings only: https://www.quantisnow.com/company/CYBN/8-k
- RSS and alerts for CYBN: https://www.quantisnow.com/docs/rss-feeds.md
